When did BIO-key International, Inc. report Q4 2025 earnings?

BIO-key International, Inc. (BKYI) reported Q4 2025 earnings on March 31, 2026 before market open.

What were BIO-key International, Inc.'s Q4 2025 revenue and EPS?

BIO-key International, Inc. reported revenue of $1.2M and diluted EPS of $-0.19 for Q4 2025.

Revenue missed the consensus estimate of $2.2M by $958.7K. EPS missed the consensus estimate of $-0.07 by $0.12.

Compared to the same quarter a year prior, revenue declined 15.1% from $1.5M a year earlier and diluted EPS grew 64.2% from $-0.53.

You can read the 8-K earnings release (0001437749-26-010506) directly on SEC EDGAR. The filing index links above go to sec.gov.

Reported March 31, 2026 · Before market open

Revenue estimate$2.2M

EPS estimate-$0.07

Date not yet announced

Q4 2025$1.2MMiss by $958.7K

Q4 2025-$0.19Miss by $0.12

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

When did BIO-key International, Inc. report Q4 2025 earnings?: BIO-key International, Inc. (BKYI) reported Q4 2025 earnings on March 31, 2026 before market open.
What were BIO-key International, Inc.'s Q4 2025 revenue and EPS?: BIO-key International, Inc. reported revenue of $1.2M and diluted EPS of $-0.19 for Q4 2025.
Did BIO-key International, Inc. beat estimates in Q4 2025?: Revenue missed the consensus estimate of $2.2M by $958.7K. EPS missed the consensus estimate of $-0.07 by $0.12.
How did BIO-key International, Inc.'s Q4 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue declined 15.1% from $1.5M a year earlier and diluted EPS grew 64.2% from $-0.53.
Where can I find BIO-key International, Inc.'s Q4 2025 SEC filings?: You can read the 8-K earnings release (0001437749-26-010506) directly on SEC EDGAR. The filing index links above go to sec.gov.